Optimizing Migraine Prevention Through Quality Improvement: Migraine ECHOQI- 8/21/2024

August 21, 2024

Sustainability of Intervention and Wrap-Up

 

Claiming Credit 

Thank you for attending the Migraine ECHOQI Session on August 21, 2024.  Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to claim your credit on the following page.

 

Target Audience

Community neurology-focused healthcare professional teams caring for patients with migraine, including neurologists, nurse practitioners, physician associates, registered nurses, quality improvement staff, practice managers, and administrative staff. 

Learning Objectives

  • Outline the plan to sustain the intervention beyond the program period 
Course summary
Available credit: 
  • 1.00 AAPA Category I Self-assessment
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Risk Management
  • 1.00 ANCC
    • 0.00 ANCC Pharmacology
  • 1.00 Participation
Course opens: 
08/21/2024
Course expires: 
08/21/2025
Event starts: 
08/21/2024 - 5:30pm EDT
Event ends: 
08/21/2024 - 6:30pm EDT
Add to calendar: 
Rating: 
0

Program Faculty Disclosures

Dr. Macone is a consultant/advisor/speaker for Theranica.

Ms. Duplin has no relevant financial relationships to disclose.

Dr. Joshi is a consultant/advisor/speaker for Amgen, Biohaven, Impel, Lilly, Lundbeck, Nerivio, and Pfizer.

Ms. Sanfratello has no relevant financial relationships to disclose

Dr. Spiewak was previously an employee for Walgreens.

Ms. Baer has no relevant financial relationships to disclose.

 

Accreditor Disclosures
The following planning committee members have no relevant financial relationships to disclose:

Linda Baer, MSPH, CHCP, Grant and Diabetes Education Manager, Boston University Chobanian & Avedesian School of Medicine, Center for Continuing Education

Natalie Sanfratello, MPH, CHCP, Senior Program Manager – Quality Improvement & Educational Programs, Boston University Chobanian & Avedesian School of Medicine, Center for Continuing Education

Julie L. White, MS, CHCP, Director, Boston University Chobanian & Avedesian School of Medicine, Center for Continuing Education

Amber Lemons, PharmD, BCPP, Director, Educational Strategy- Neuroscience, Clinical Care Options, LLC

Jodie Malhotra, PharmD, Director, Scientific Services- Neuroscience, Clinical Care Options, LLC

Horacio Rodriguez, Vice President, Global Neuroscience, Clinical Care Options, LLC

 

Off-Label Discussion
The faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.

 

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

 

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 

Nursing Contact Hours: 1.00, of which 0 are eligible for pharmacology credit 

 

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

 

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation. 

 

 

 

Available Credit

  • 1.00 AAPA Category I Self-assessment
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Risk Management
  • 1.00 ANCC
    • 0.00 ANCC Pharmacology
  • 1.00 Participation
Please login or register to take this course.